WallStreetZenWallStreetZen

NASDAQ: TENX
Tenax Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for TENX

Based on 1 analyst offering 12 month price targets for Tenax Therapeutics Inc.
Min Forecast
$30.00+697.87%
Avg Forecast
$30.00+697.87%
Max Forecast
$30.00+697.87%

Should I buy or sell TENX stock?

Based on 1 analyst offering ratings for Tenax Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TENX stock forecasts and price targets.

TENX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-20

1 of 1

Forecast return on equity

Is TENX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36.19%

Forecast return on assets

Is TENX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TENX revenue forecast

What is TENX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$2.0M
Avg 2 year Forecast
$8.3M
Avg 3 year Forecast
$140.4M

TENX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TENX$3.76$30.00+697.87%Strong Buy
ENVB$1.01$10.00+890.10%Buy
VCNX$6.10N/AN/A
PYPD$4.60$10.00+117.39%Hold
CELZ$5.21N/AN/A

Tenax Therapeutics Stock Forecast FAQ

Is Tenax Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TENX) stock is to Strong Buy TENX stock.

Out of 1 analyst, 1 (100%) are recommending TENX as a Strong Buy, 0 (0%) are recommending TENX as a Buy, 0 (0%) are recommending TENX as a Hold, 0 (0%) are recommending TENX as a Sell, and 0 (0%) are recommending TENX as a Strong Sell.

If you're new to stock investing, here's how to buy Tenax Therapeutics stock.

What is TENX's revenue growth forecast for 2025-2027?

(NASDAQ: TENX) Tenax Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.34%.

Tenax Therapeutics's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast TENX's revenue for 2025 to be $3,916,490, with the lowest TENX revenue forecast at $3,916,490, and the highest TENX revenue forecast at $3,916,490. On average, 1 Wall Street analysts forecast TENX's revenue for 2026 to be $16,273,016, with the lowest TENX revenue forecast at $16,273,016, and the highest TENX revenue forecast at $16,273,016.

In 2027, TENX is forecast to generate $274,878,851 in revenue, with the lowest revenue forecast at $274,878,851 and the highest revenue forecast at $274,878,851.

What is TENX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: TENX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is TENX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TENX price target, the average TENX price target is $30.00, with the highest TENX stock price forecast at $30.00 and the lowest TENX stock price forecast at $30.00.

The Wall Street analyst predicted that Tenax Therapeutics's share price could reach $30.00 by Feb 20, 2025. The average Tenax Therapeutics stock price prediction forecasts a potential upside of 697.87% from the current TENX share price of $3.76.

What is TENX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: TENX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.